These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 132717)

  • 1. Development of specific nonreactivity in human cadaveric renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Tissue Antigens; 1976 May; 7(5):281-90. PubMed ID: 132717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.
    Rashid A; Sengar DP; Harris JE
    Clin Exp Immunol; 1979 Jun; 36(3):521-7. PubMed ID: 158449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Dec; 22(3):409-18. PubMed ID: 131667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of allograft function to the development of donor specific cellular nonreactivity in human cadaveric allograft recipients.
    Rashid A; Sengar DP; Couture RA; Harris JE
    Trans Am Soc Artif Intern Organs; 1976; 22():229-33. PubMed ID: 133496
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated lympholysis studies in renal allograft recipients.
    Goulmy E; Persijn G; Blokland E; D'Amaro J; van Rood JJ
    Transplantation; 1981 Mar; 31(3):210-7. PubMed ID: 7015616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
    Hajek-Rosenmayr A; Wolf A
    Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between MLC stimulation and graft survival in living related and cadaver transplants.
    Cochrum KC; Salvatierra O; Belzer FO
    Ann Surg; 1974 Oct; 180(4):617-22. PubMed ID: 4278045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte function in patients treated with monoclonal anti-T3 antibody for acute cadaveric renal allograft rejection.
    Bowen A; Edwards LC; Gailiunas P; Helderman JH
    Transplantation; 1984 Nov; 38(5):489-93. PubMed ID: 6388070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid MLC test for selection of allograft recipients for cadaveric kidneys.
    Butt KM; Parsa I; Kountz SL
    Surg Forum; 1973; 24():272-3. PubMed ID: 4282520
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR.
    Ghobrial II; Morris AG; Booth LJ
    Transpl Int; 1994; 7(6):420-7. PubMed ID: 7865106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
    Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
    Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1987 Feb; 43(2):205-10. PubMed ID: 2949404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes.
    Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
    Transplantation; 1987 Jan; 43(1):41-6. PubMed ID: 2948309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lymphocyte reactivity in patients with cancer, systemic lupus erythematosus and renal allografts.
    Suciu-Foca N; Herter FP; Buda JA; Reemtsma K
    Oncology; 1975; 31(3-4):125-32. PubMed ID: 127968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the mixed leucocyte culture reaction by plasma from renal transplatn recipients.
    Singal DP; Younglai EV; Naipaul N
    Tissue Antigens; 1975 Feb; 5(1):19-25. PubMed ID: 124479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1977 Apr; 28(1):123-9. PubMed ID: 140776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential mixed lymphocyte culture after kidney transplantation: induction of tolerance or sensitization.
    Creemers P; Du Toit E; Cassidy MJ; Kahn D
    Nephron; 1997; 75(2):166-70. PubMed ID: 9041536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant mixed lymphocyte culture still has an impact on graft survival.
    El-Agroudy AE; Ismail AM; El-Chenawy FA; Shehab El-Din AB; Ghoneim MA
    Am J Nephrol; 2004; 24(3):296-300. PubMed ID: 15118343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to donor B lymphocytes and mixed lymphocyte culture blocking in cadaveric renal transplantation.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Uittenbogaart C; Pennisi AJ; Malekzadeh MH; Fine RN
    Transplantation; 1978 Apr; 25(4):169-72. PubMed ID: 147530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.